Learn About NUT Carcinoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top NUT Carcinoma Local Doctors?
Elite
Highly rated in
85
conditions

University Hospital Erlangen

Erlangen, BY, DE 91054

Abbas Agaimy is in Erlangen, Germany. Agaimy is rated as an Elite expert by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 85 other conditions, according to our data. His top areas of expertise are Salivary Gland Tumors, Gastrointestinal Stromal Tumor, NUT Carcinoma, and Adult Soft Tissue Sarcoma.

Elite
Highly rated in
20
conditions
Hematology Oncology
Oncology

Dana-Farber Cancer Institute

450 Brookline Ave 
Boston, MA 2215

Geoffrey Shapiro is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Shapiro has been practicing medicine for over 34 years and is rated as an Elite doctor by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are NUT Carcinoma, Non-Small Cell Lung Cancer NCSLC, Lung Cancer, and Ovarian Cancer. He is licensed to treat patients in Massachusetts. Dr. Shapiro is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn more
Distinguished
Highly rated in
13
conditions

University Of Milan

Milan, IT 

Giuseppe Pelosi is in Milan, Italy. Pelosi is rated as a Distinguished expert by MediFind in the treatment of NUT Carcinoma. He is also highly rated in 13 other conditions, according to our data. His top areas of expertise are Large-Cell Lung Carcinoma, NUT Carcinoma, Squamous Cell Lung Carcinoma, and Neuroendocrine Tumor.

What are the Latest Advances for NUT Carcinoma?
Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma.
Clinical, Radiographic, Pathologic Characterization and Survival Outcomes of Nuclear Protein of the Testis Carcinoma.
Tired of the same old research?
Check Latest Advances
Incidence of NUT carcinoma in Western Australia from 1989 to 2014: a review of pediatric and adolescent cases from Perth Children's Hospital.
What are the latest NUT Carcinoma Clinical Trials?
A Phase 1/2 Study of the Bromodomain Inhibitor ZEN003694 in Combination With Etoposide/Platinum in Patients With NUT Carcinoma
Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1 Study of BET Bromodomain Inhibitor ZEN003694 in Combination With the CDK4/6 Inhibitor Abemaciclib in Patients With NUT Carcinoma and Other Solid Tumors